Invention Grant
US08653117B2 Composition comprising at least one oxazoline to inhibit migration of langerhans cells, and uses thereof
有权
包含至少一种恶唑啉以抑制朗格汉斯细胞迁移的组合物及其用途
- Patent Title: Composition comprising at least one oxazoline to inhibit migration of langerhans cells, and uses thereof
- Patent Title (中): 包含至少一种恶唑啉以抑制朗格汉斯细胞迁移的组合物及其用途
-
Application No.: US12352973Application Date: 2009-01-13
-
Publication No.: US08653117B2Publication Date: 2014-02-18
- Inventor: Philippe Msika , Nathalie Piccardi , Antoine Piccirilli
- Applicant: Philippe Msika , Nathalie Piccardi , Antoine Piccirilli
- Applicant Address: FR Courbevoie
- Assignee: Laboratoires Expanscience
- Current Assignee: Laboratoires Expanscience
- Current Assignee Address: FR Courbevoie
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Priority: FR0116917 20011227
- Main IPC: A61K31/421
- IPC: A61K31/421 ; A61K38/02 ; A61P35/00

Abstract:
The invention concerns a composition containing at least an oxazolin, optionally combined with at least a compound such as a metalloprotease inhibitor, a PKC inhibitor, an anti-inflammatory agent, a soothing agent, an immunosuppressor, an ion chelating agent, an alkanolamide, an oxazolidinone and a carbamic acid derivative. The invention also concerns the use of such a composition as medicine, in particular for preventing or treating skin pathologies of allergic and/or inflammatory and/or irritative origin or resulting from a danger signal. The invention further concerns a method for cosmetic treatment of sensitive, irritated, intolerant, allergy-prone, ageing skin and/or mucosa exhibiting skin barrier disorder, or exhibiting non-pathological immunologic imbalance, which consists in applying such composition on the skin and/or mucosa.
Public/Granted literature
- US20090137453A1 COMPOSITION COMPRISING AT LEAST ONE OXAZOLINE TO INHIBIT MIGRATION OF LANGERHANS CELLS, AND USES THEREOF Public/Granted day:2009-05-28
Information query
IPC分类: